Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS have more depression and stress due to high androgen levels, not obesity or insulin resistance.

Androgens, male hormones, affect physical and mental functions, with a decrease leading to health issues like muscle loss, bone disease, and depression, and more research is needed on long-term effects and treatments.

Male pattern baldness in medical students is linked to higher depression, loneliness, and internet addiction.

Cirrhosis affects quality of life with various symptoms, requiring a holistic, multidisciplinary approach for management.

Trichotillomania is a challenging-to-treat impulse-control disorder where individuals pull out their hair, more common in females, with some treatments showing benefits.

VEGF and its receptor might cause hair loss.

Condensed nanofat with fat grafts effectively improves atrophic facial scars.

Stress affects skin health and emotional well-being should be considered in skin disease treatment.

A hormone linked to collagen helps hair grow back in mice after chemotherapy, and may also prevent bone loss.

Most patients experience temporary hair loss after ECMO, but it usually grows back within 6 months without treatment.

Men with moderate hair loss had the best spatial thinking, and long-term DHT might affect cognition.

Hair loss is significantly linked to symptoms like dry hair, scalp issues, addiction to tobacco or coffee, anxiety, and digestive problems.

Acne treatment, including isotretinoin, improves quality of life and does not worsen depression.

Women with PCOS face higher risks of diabetes and heart disease, and these risks increase with obesity.

Minoxidil promotes hair growth in male pattern baldness.

Treating sleep apnea in young obese women with PCOS can improve heart health and insulin sensitivity.

Female Pattern Hair Loss affects women's self-esteem and needs more research for better treatment.

Metformin improves hair growth and menstrual frequency in women with PCOS and hirsutism.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

Antidepressants may improve or resolve scalp dysesthesia in most patients.

Bimatoprost, a glaucoma medication, may also help treat hair loss.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

Certain gene variants may contribute to high androgen levels in women with polycystic ovary syndrome.

Spironolactone helps reduce pain and lesions in hidradenitis suppurativa patients, and lower doses are also effective.

Low-level laser therapy may improve hair regrowth and thickness for androgenetic alopecia, but more research is needed.

Laser treatment increases hair density and thickness safely in women with hair loss.

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.

The document concludes that there is no clear definition of adequate health insurance, and a consistent method to measure underinsurance is needed.

New treatments for PCOS show promise, but no current medication treats all aspects of the condition.

Menstrual disorders are common in adolescents and can be influenced by weight, activity, and health issues, requiring careful evaluation and more research for effective treatment.